Media
FOR IMMEDIATE RELEASE
March 2024
Provell Pharmaceuticals and Mark Cuban Cost Plus Drug Company Bring Leading Hypothyroid Drug, Euthyrox®, to U.S. Patients at Low-Cost Prices through Direct-to-Consumer Model
January 2024
Provell Pharmaceuticals is proud to leverage GoodRx to raise awareness around EUTHYROX®, a cost-effective levothyroxine treatment. EUTHYROX® is priced similarly to generics and has unique blister packaging that helps preserve potency. GoodRx coupons are available for retail pharmacies, and EUTHYROX® offers home delivery.
June 2023
Provell Pharmaceuticals is a 2023 Winner of the Viddy Awards! The EUTHYROX® Promotional Video has been honored with a GOLD Award in the Non-Broadcast | Short Form Web Videos < 3 Minutes | Branded Content category. Click the link below to view the video: Click here
April 2023
Provell Pharmaceuticals Awarded a Spot on FSS, DAPA Contract Vehicles Through Lovell Government Services
All Videos
April 27, 2022 Provell Pharmaceuticals Announces FDA Approval of Euthyrox® (levothyroxine sodium) 90-count pack size for the U.S. Market. Honey Brook, PA — Provell Pharmaceuticals, LLC (Provell) announced today that the FDA has granted approval for Euthyrox® (levothyroxine sodium) 90-count pack size. This further enhances the product offering for patients and physicians within this important drug category. Euthyrox® (levothyroxine sodium) tablets are bioequivalent and therapeutically equivalent to Synthroid® (levothyroxine sodium) tablets. The current indications and usage for Euthyrox® are as follows: Hypothyroidism EUTHYROX is indicated in pediatric and adult patients as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression EUTHYROX is indicated in pediatric and adult patients as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. “The recent FDA approval of a new 90-count pack size of Euthyrox® is an important milestone for Provell Pharmaceuticals. The 90-count pack size is the most dispensed quantity at pharmacies across the country. This now provides patients, physicians, and pharmacists alike an important differentiated option. We will continue to provide the highest quality products for the benefit of patients struggling with thyroid disease. We look forward to watching the continued growth of this product in the coming months and years.” –Jim Small, CEO Provell Pharmaceuticals, LLC About Provell Pharmaceuticals, LLC Located in Honey Brook, PA, Provell is a small, privately held healthcare company specializing in the marketing and distribution of world class leading pharmaceutical products in the United States. Their goal is to provide unique and innovative delivery of pharmaceutical products to help enhance drug quality, increase patient adherence, resulting in improved patient outcomes. Provell entered an exclusive marketing and distribution agreement with Merck KGaA Darmstadt, Germany on September 28, 2013 for the U.S. Market. Euthyrox® (levothyroxine sodium) is a registered trademark of Merck KGaA Darmstadt, Germany. Synthroid® is a registered trademark of AbbVie, Inc. No use of any Provell Pharmaceuticals, Euthyrox®, and Merck KGaA Darmstadt, Germany trademark, trade name, or trade dress may be made without the prior written authorization of Provell Pharmaceuticals, LLC and Merck KGaA, Darmstadt, Germany. Please visit www.provellpharma.com for more information Email us: info@provellpharma.com For further information and updated labeling visit: dailymed.nlm.nih.gov
March 23, 2022 Drug Enforcement Agency Prescription Drug Take-Back Day and PPSWG’s MyOldMeds.com Year-Round Household Medicine Disposal Locator The Drug Enforcement Agency (DEA) National Prescription Drug Take-Back Day is on Saturday, April 30th, 2022. From 10:00 AM to 2:00 PM, the DEA will provide the public with a free and convenient opportunity to dispose of unwanted, unused, and expired household medicines. To find a location near you, please visit the event’s website and use the Collection Site Locator Tool. What if I can’t make it to the DEA National Prescription Drug Take-back Day? Provell Pharmaceuticals recognize that you might not be able to make it to the DEA Prescription Drug Take-Back Day. So, it wants you to know about MyOldMeds.com which features a Locator Tool that can help you choose year-round from more than 22,000 verified locations in all 50 states that have secure unwanted or expired medicine disposal kiosks, and/or provide free in-home disposal kits upon request. Additionally, the Locator Tool provides disposal sites’ hours of operation, hours of collection, what is collected, and other helpful information. MyOldMeds.com also provides information on proper use, proper storage, and proper disposal of unwanted or expired household medicine. Press Contact: info@provellpharma.com
January 22, 2020 Provell Pharmaceuticals, LLC Announces the launch of MyOldMeds.com as a member of the Pharmaceutical Product Stewardship Work Group (PPSWG). The Pharmaceutical Product Stewardship Work Group (PPSWG) has re-launched a website to provide information about securely storing and disposing of unwanted, unused, or expired medicines from households, information about following instructions provided with your medicines, and a Kiosk Site Locator. PPSWG has updated the MyOldMeds.com website to assist in improving the understanding of appropriate pharmaceutical product storage and disposal options for households. The MyOldMeds.com website addresses the following important functions and provides instructions on each: 1. Adhering to instructions provided with your medicines, including labeling information and Medication Guides; 2. Securely storing medicine; and 3. Disposing of unwanted, unused, or expired medicines from households. The website also features a Kiosk Site Locator, providing a comprehensive map of kiosk sites throughout all fifty states. About PPSWG The Pharmaceutical Product Stewardship Work Group (PPSWG), a US-based non-profit membership association comprised of producers of pharmaceutical products (including branded and generic prescription and over-the-counter pharmaceutical products), re-launched the MyOldMeds.com website on January 22, 2020. https://www.med-project.org/ Press Contact: Stanton J. Barrett, VP Membership & Communications PPSWG sbarrett@ppswg.org 202-580-6298 About Provell Pharmaceuticals, LLC Located in Honey Brook, PA, Provell is a small, private healthcare company specializing in the marketing and distribution of world class leading pharmaceutical products in the United States. Their goal is to provide unique and innovative delivery of pharmaceutical products to help enhance drug quality, increase patient adherence, resulting in improved patient outcomes. Provell entered an exclusive marketing and distribution agreement with Merck KGaA Darmstadt, Germany on September 28, 2013 for the U.S. Market. Euthyrox® (levothyroxine sodium) is a registered trademark of Merck KGaA Darmstadt, Germany. No use of any Provell Pharmaceuticals, Euthyrox®, and Merck KGaA Darmstadt trademark, trade name, or trade dress may be made without the prior written authorization of Provell Pharmaceuticals, LLC and Merck KGaA, Darmstadt, Germany. For More Information: info@provellpharma.com dailymed.nlm.nih.gov
September 14th, 2018 Provell Pharmaceuticals Announces the FDA Approval of Euthyrox® (levothyroxine sodium) for the U.S. Market. Honey Brook, PA — Provell Pharmaceuticals, LLC (Provell) announced today that the FDA has granted approval for Euthyrox® (levothyroxine sodium). Provell is also pleased to share that according to the FDA, it was determined that Euthyrox® (levothyroxine sodium) tablets to be bioequivalent and therapeutically equivalent to Synthroid® (levothyroxine sodium) tablets. The FDA Orange Book is updated to reflect the bioequivalence and therapeutic interchangeability within the AB2 class. Please click here to access this report. “The FDA approval of Euthyrox for the U.S. thyroid hormone replacement market is the beginning of Provell Pharmaceuticals’ goal to bring a valuable alternative product to this very common medical condition, hypothyroidism. We are very excited about our market entry in early 2019.” –Jim Small, CEO Provell Pharmaceuticals, LLC About Provell Pharmaceuticals, LLC Located in Honey Brook, PA, Provell is a small, private healthcare company specializing in the marketing and distribution of world class leading pharmaceutical products in the United States. Their goal is to provide unique and innovative delivery of pharmaceutical products to help enhance drug quality, increase patient adherence, resulting in improved patient outcomes. Provell entered an exclusive marketing and distribution agreement with Merck KGaA Darmstadt, Germany on September 28, 2013 for the U.S. Market. Euthyrox® (levothyroxine sodium) is a registered trademark of Merck KGaA Darmstadt, Germany. No use of any Provell Pharmaceuticals, Euthyrox®, and Merck KGaA Darmstadt, Germany trademark, trade name, or trade dress may be made without the prior written authorization of Provell Pharmaceuticals, LLC and Merck KGaA, Darmstadt, Germany. For More Information: info@provellpharma.com dailymed.nlm.nih.gov